Table 4.
Characteristics of the respondents.
| Number [%] | Years [SD] | Type of Surgery | Number of Patients with TSA [%] | Number of Patients with Radiotherapy [%] | Urban Region | Years Lived with Disease [SD] | Average Number of Concomitant Diseases | Type of Therapy | Utility Values [SD] | |
|---|---|---|---|---|---|---|---|---|---|---|
| Male | 26 [27.4%] | 53.54 [14.41] | TSA * | 25 [96.2%] | 4 [15.4%] | 77% | 13.76 [10.66] | 5 | 18—SSA 3—SSA + DA 5—No treatment |
0.74 [0.24] |
| Female | 69 [72.6%] | 58.5 [12.84] | TSA | 69 [100%] |
12 [17.4%] | 82.6% | 14.4 [11.14] | 7 | 40- SSA 8–SSA + pegvisomant 5-SSA + Da 12-no treatment 2-pegvisomant 2-DA |
0.70 [0.22] |
* TSA—Transsphenoidal adenectomy.